Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age. A Multicenter Clinical Study

NCT03177863 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.

NCT NCT03177863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03177863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age. A Multicenter Clinical Study
Lead sponsor
Sahlgrenska University Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 12, 2017
Completion date
June 24, 2021
Enrollment
125 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cin2, therapy